1159828-70-2 Usage
Description
1H-Pyrazolo[4,3-c]pyridine,4-chloro-6-Methylis a chemical compound with the molecular formula C8H6ClN3. It is a derivative of pyrazolopyridine and contains a chlorine and a methyl group. 1H-Pyrazolo[4,3-c]pyridine,4-chloro-6-Methylis often used in the pharmaceutical industry as a building block for the synthesis of various pharmacologically active compounds. It has also been studied for its potential biological activities, especially in the treatment of various diseases. Due to its unique structure and potential therapeutic effects, 1H-Pyrazolo[4,3-c]pyridine,4-chloro-6-Methylmay have applications in drug discovery and development.
Uses
Used in Pharmaceutical Industry:
1H-Pyrazolo[4,3-c]pyridine,4-chloro-6-Methylis used as a building block for the synthesis of various pharmacologically active compounds. Its unique structure and potential therapeutic effects make it a valuable component in the development of new drugs.
Used in Drug Discovery and Development:
1H-Pyrazolo[4,3-c]pyridine,4-chloro-6-Methylis used as a potential candidate for the treatment of various diseases. Its biological activities and potential therapeutic effects are being studied to explore its applications in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1159828-70-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,9,8,2 and 8 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1159828-70:
(9*1)+(8*1)+(7*5)+(6*9)+(5*8)+(4*2)+(3*8)+(2*7)+(1*0)=192
192 % 10 = 2
So 1159828-70-2 is a valid CAS Registry Number.
1159828-70-2Relevant articles and documents
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
-
Paragraph 0319; 0320, (2014/05/20)
The present invention provides, in part, compounds of Formula I: and pharmaceutically acceptable salts thereof and N-oxides of the foregoing; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds, salts or N-oxides, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, impulsivity, compulsive gambling, overeating, autism spectrum disorder, MCI, age-related cognitive decline, dementia, RLS, Parkinson's disease, Huntington's chorea, anxiety, depression, MDD, TRD, and bipolar disorder.
